October 23, 2025
Distributed Operations: Building Competitive Advantage in Biotech Through Strategic Outsourcing
Small companies face inherent scale and resource constraints. By contrast, global CROs offer access to large teams, specialized instrumentation, and around-the-clock workflows. This webinar will examine what discovery work to perform in-house versus externally, and how to structure outsourcing as a durable strategic advantage.
Panelists will share practical experiences ranging from fully outsourced models to hybrid approaches within large pharma. Topics include make-vs-buy decision frameworks, maintaining chemical intuition, safeguarding IP and data, and adapting strategies to tariff and geopolitical uncertainty.
Register for the webinar to learn more.
Key Discussion Areas
-
Make vs. Buy Decisions: Evaluating when internal execution creates value versus when CRO capacity is more effective.
-
Portfolio Diversification: Using outsourcing to broaden targets and reduce dependency on single programs.
-
Quality and Oversight: Controls for assay transfer, formulation reproducibility, and compartmentalization of sensitive work.
-
CRO Selection: Beyond cost — assessing boutique expertise, equipment, and track record.
-
Geopolitics and Risk: Tariffs, IP jurisdiction, and diversification of supply chains.
Other posts you might be interested in
View All Posts
Webinars
1 min
October 23, 2025
Augmented Design: Practical Applications of LLMs and Agentic Workflows in Medicinal Chemistry
Read More
Webinars
1 min
October 23, 2025
Distributed Operations: Building Competitive Advantage in Biotech Through Strategic Outsourcing
Read More
Webinars
1 min
October 23, 2025
OpenADMET Blind Challenge
Read More